Postnatal efficacy of Momordica charantia peel, pulp, seed and whole fruit extract in the detoxication pathway of suckling neonates and lactating mice

Cancer Letters

Volumn 122, Issue 1-2, 1998, Pages 121-126

  Singh, Anjali ^a   Singh, Satya Prakash ^a   Bamezai, Ramesh ^a  

^a Sch Life Sci   (India)

Author keywords

Detoxication pathway; Lactating mice; Momordica charantia; Neonates; Postnatal

Indexed keywords

CYTOCHROME B5; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; LIVER ENZYME; MOMORDICA CHARANTIA EXTRACT; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; LACTATION; LIVER LEVEL; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; SUCKLING;

ANIMALS; ANIMALS, SUCKLING; CUCURBITACEAE; GLUTATHIONE; LACTATION; LIVER; METABOLIC DETOXICATION, DRUG; MICE; PLANT EXTRACTS;

ANIMALIA; MOMORDICA; MOMORDICA CHARANTIA;

EID: 0032498248     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00381-9     Document Type: Article

References (28)

1. Biswas A.R., Ramaswamy S., Bapna J.S. Analgesic effect of Momordica charantia seed extract in mice and rats. J. Ethnopharmacol. 31:1991;115-118.
2. Bourinbaiar A.S., Lee-Huang S. Potentiation of anti-HIV activity of antiinflammatory drugs, dexamethasone and indomethacine, by MAP30, the antiviral agent from bitter melon. Biochem. Biophys. Res. Commun. 208:1995;779-785.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res. 14:1992;2024s-2029s.
5. Ellmann G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
6. Guevara A.P., Lim-Sylianco C., Dayrit F., Finch P. Antimutagens from Momordica charantia. Mutat. Res. 230:1990;121-126.
7. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249:1974;7130-7139.
8. Karnik H.B., Sonawane B.R., Adkins J.S., Mohla S. High dietary fat feeding during perinatal development of rats alters hepatic drug metabolism of progeny. Dev. Pharmacol. Ther. 14:1990;135-140.
9. Kellof G.J., Boone C.W., Malone W.E., Steele V.E. Chemoprevention clinical trials. Mutat. Res. 267:1992;292-295.
10. Little M.T.E., Hahn P. Diet and metabolic development. FASEB J. 4:1990;2605-2611.
11. Ng T.B., Wong C.M., Li W.W., Yeung H.W. Peptides with antilipolytic and lipogenic activities from seeds of the bitter gourd Momordica charantia (family cucurbitaceae). Gen. Pharmacol. 18:1987;275-281.
12. Ng T.B., Tam P.P., Hon W.K., Choi H.L., Yeung H.W. Effects of momorcharins on ovarian response to gonadotropin-induced superovulation in mice. Int. J. Fertil. 33:1988;123-128.
13. Ng T.B., Chan W.Y., Yeung H.W. Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from cucurbitaceae plants. Gen. Pharmacol. 23:1992;579-590.
14. Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem. 239:1964;2370-2378.
15. Puglia C.D., Powell S.R. Inhibition of cellular antioxidants: a possible mechanism of toxic cell injury. Environ. Heal. Persp. 57:1984;307-311.
16. A.R. Rao, 7,12-Dimethylbenz(a)anthracene-induced perinatal carcinogenesis and its modulation by butylated hydroxyanisole in mice, in: N.P. Napalkov, J.M. Rice, L. Tomatis, H. Yamasaki (Eds.), Perinatal Multigeneration Carcinogenesis, IARC (Publication 96), Lyon, 1989, pp. 63-73.
17. Rybak S.M., Lin J.J., Newton D.L., Kong H.F., Monks A., Chen H.-C., Huang P.L., Lee-Huang S. In vitro anti-tumor activity of the plant ribosome inactivating proteins MAP30 and GAP31. Int. J. Oncol. 5:1994;88-94.
18. Shabib B.A., Khan L.A., Rahman R. Hypoglycemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-biphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem. J. 292:1993;267-270.
19. Sharma S., Stutzman J.D., Kelloff G.J., Steele V.E. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res. 54:1994;5848-5855.
20. Slaga T.J. Inhibition of the induction of cancer by antioxidants. Adv. Exp. Med. Biol. 369:1995;167-174.
21. Singh A., Singh S.P., Bamezai R. Postnatal modulation of hepatic biotransformation system enzymes via translactational exposure of F1 mouse pups to turmeric and curcumin. Cancer Lett. 96:1995;87-93.
22. Singh A., Singh S.P., Bamezai R. Effect of arecoline on the curcumin-modulated hepatic biotransformation system enzymes in lactating mice and translactationally exposed F1 pups. Nutr. Cancer. 25:1996;101-110.
23. Singh A., Singh S.P., Bamezai R. Postnatal efficacy of arecoline on chlorophylline-modulated hepatic biotransformation system enzymes in suckling neonate and lactating mice. Teratogen. Carcinogen. Mutagen. 16:1996;89-96.
24. K. Snell, Developmental enzyme pathology, in: K. Snell (Ed.), Developmental Toxicology, Praeger, New York, 1992, pp. 299-399.
25. Sparnins V.L., Venegas P.L., Wattenberg L.W. Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. J. Natl. Cancer Inst. 68:1982;493-496.
26. Wattenberg L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 52:1992;2085s-2091s.
27. Yang C.S., Smith T.J., Hong J.-Y. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res. 54:1994;1982s-1986s.
28. Zhu Z.J., Zhong Z.C., Luo Z.Y., Xiao Z.Y. Studies on the active constituents of Momordica charantia. L. Yao. Hsueh. Pao. 25:1990;898-903.